Clinical Trial: A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer

U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07240857) titled 'A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer' on Aug. 23.

Brief Summary: An exploratory clinical study evaluating the safety and efficacy of ACT#001 chimeric antigen receptor T-cell (CAR-T cell) local injection in the treatment of castration-resistant prostate cancer.

Study Start Date: Dec. 31

Study Type: INTERVENTIONAL

Condition: Castration-Resistant Prostate Cancer (CRPC)

Intervention: BIOLOGICAL: Intraprostatic or localized lesion injection of ACT#001-PSMA CAR-T cells under transrectal ultrasound (...